Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Nystop 100Mu/ Gm Powder 15 Gm By Perrigo Co

Image 0 of Nystop 100Mu/ Gm Powder 15 Gm By Perrigo CoImage 1 of Nystop 100Mu/ Gm Powder 15 Gm By Perrigo Co

Nystop 100Mu/ Gm Powder 15 Gm By Perrigo Co

Call for Price

Nystop 100Mu/ Gm Powder 15 Gm By Perrigo Co. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD2481752/RXB10020882/RXA601305
Size : 15 GM
Selling UoM : EA
NDC: 00574-2008-15
UPC Barcode : 305742008155
Supplier: 0050001922 PERRIGO CO
Supplier Material : 200815
Generic Code : 007284 NYSTATIN TOPICAL POWDER 100000/G
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Generic RX

Have a question?

  Call for Price

Product Description.:

Powder , yellow

Nystatin is a polyene antifungal antibiotic obtained from Streptomyces nursei.The molecular formula for Nystatin is C47H75NO17.

INDICATIONS AND USAGE

Nystatin Topical Powder is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.

This preparation is not indicated for systemic, oral, intravaginal or ophthalmic use.

CONTRAINDICATIONS

Nystatin Topical Powder is contraindicated in patients with a history of hypersensitivity to any of its components.

PRECAUTIONS

General

Nystatin Topical Powder should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.

If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated.It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.

INFORMATION FOR THE PATIENT

Patients using this medication should receive the following information and instructions:

1. The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.
2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.
3. If symptoms of irritation develop, the patient should be advised to notify the physician promptly.

Laboratory Tests

If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.